About Protea Biosciences
Protea Biosciences is a publicly listed company based in Morgantown (United States) founded in 2001. Mass spectrometry imaging technologies for proteomics are provided. Protea Biosciences has raised $13.2 million across 20 funding rounds from investors including West Virginia Jobs Investment Trust. The company has 25 employees. Protea Biosciences offers products and services including LAESI Services, MALDI Services, LCMS Services, and ProteaPrep Cell Lysis Kits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems. Its legal entity is PROTEA BIOSCIENCES GROUP, INC. Its competitors include 908 Devices, Advion and Impedimed; 3 of its 3 listed competitors have raised funding.
Company details
Protea Biosciences was founded in 2001 and is based in Morgantown, United States, within the biotechnology sector. Mass spectrometry imaging technologies, such as the LAESI DP-1000 Direct Ionization System, are supplied alongside bioanalytical products including REDIchip. Services encompass mass spectrometry imaging, proteomics, protein characterization, and small molecule analysis. Molecular identification for small and large molecules is handled, along with tissue analytics to generate molecular profiles from biological samples.
- Headquarters Morgantown, United States
- Employees 25
- Stage Public
- SectorsHealthcare
- Website proteabio.com/cgi-sys/suspendedpage.cgi
- Social LinkedIn X Facebook
- Legal Name Protea Biosciences Group, Inc.
- Annual Revenue$2.45 M (USD)31as on Dec 31, 2016
- Net Profit-$15.65 M (USD)-63as on Dec 31, 2016
- EBITDA-$5.49 M (USD)23as on Dec 31, 2016
- Total Equity Funding$13.2M (USD)
in 20 rounds
- Latest Funding Round$631.68K (USD), Post-IPO
Nov 2016
- Investors
- Employee Count25
Products & Services of Protea Biosciences
Protea Biosciences offers a comprehensive portfolio of products and services, including LAESI Services, MALDI Services, LCMS Services, and ProteaPrep Cell Lysis Kits.
Direct ionization system for biomolecule analysis in research.
Matrix-assisted laser desorption for sample imaging.
Liquid chromatography-mass spectrometry for proteomics.
Kits for cell lysis in protein analysis.
Funding Insights of Protea Biosciences
Protea Biosciences has successfully raised a total of $13.2M across 20 strategic funding rounds. The most recent funding activity was a Post-IPO round of $631.68 thousand completed in November 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.2M
- Total Rounds 20
- Last Round Post-IPO — $631,680
- First Round $1.7M
(Nov 2009)
- Investors Count 1
Latest 10 of 20 funding rounds of Protea Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2016 | $631,680 | Post-IPO | – | – | – |
| Sep 2016 | $1.74M | Post-IPO | – | – | – |
| Jun 2016 | $691,000 | Post-IPO | – | – | – |
| Sep 2015 | $452,500 | Post-IPO | – | – | – |
| Apr 2015 | $5.27M | Post-IPO | – | – | – |
| Nov 2014 | $4.43M | Post-IPO | – | – | – |
| Apr 2014 | $775,000 | Post-IPO | – | – | – |
| Oct 2013 | $275,000 | Debt – Conventional | – | – | – |
| Oct 2013 | $700,000 | Series A | – | – | – |
| Sep 2013 | $345,000 | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Protea Biosciences
Protea Biosciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include West Virginia Jobs Investment Trust.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital funding is provided to innovative entrepreneurs. | 1992 | wvjit.org | Charleston, United States |
Investor details for Protea Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Protea Biosciences
4 dated milestones of Protea Biosciences across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Protea Biosciences is founded.
- Funding First funding round of $1.7M.
- Funding Latest funding round, Post-IPO, of $632K.
- IPO Lists on the stock exchange (IPO).
Competitors of Protea Biosciences
Protea Biosciences has 3 listed competitors in our database, 3 of them funded. They include 908 Devices, Advion and Impedimed.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 908devices.com | 2012 | Boston, United States | $68.22M | 93 | Handheld chemical detection devices are manufactured using mass spectrometry. | |
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| impedimed.com | 1999 | Carlsbad, United States | $3.44M | 76 | Technologies for non-invasive fluid status assessment and monitoring are developed. |
Detailed competitors of Protea Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Protea Biosciences
Websites that share an audience with Protea Biosciences (proteabio.com).
Websites whose visitors overlap most with Protea Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bio.ijs.si | bio.ijs.si | 100% | – | ||
| abdserotec.com | 84% | View details | |||
themedicalbiochemistrypage.org | themedicalbiochemistrypage.org | 84% | #941,968 | – | |
| wakodiagnostics.com | 84% | View details | |||
| bioexpress.com | 84% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Protea Biosciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Protea Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Protea Biosciences
Complete news archive for Protea Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Protea Biosciences
Protea Biosciences was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Protea Biosciences is headquartered in Morgantown, United States. It is registered at Morgantown, West Virginia, United States.
Protea Biosciences is a funded company, having raised a total of $13.2M across 20 funding rounds to date. The company's 1st funding round was a Series A of $345K, raised on Nov 2009.
Protea Biosciences has 25 employees.
Annual revenue of Protea Biosciences is $2.45M as on Dec 31, 2016.
Protea Biosciences was founded in 2001 and is based in Morgantown, United States, within the biotechnology sector. Mass spectrometry imaging technologies, such as the LAESI DP-1000 Direct Ionization System, are supplied alongside bioanalytical products including REDIchip. Services encompass mass spectrometry imaging, proteomics, protein characterization, and small molecule analysis. Molecular identification for small and large molecules is handled, along with tissue analytics to generate molecular profiles from biological samples.
Protea Biosciences's top competitors include 908 Devices, Impedimed and Advion.
Protea Biosciences offers LAESI Services, MALDI Services, LCMS Services, and ProteaPrep Cell Lysis Kits.
Protea Biosciences has 1 investor. Key investors include West Virginia Jobs Investment Trust.
Protea Biosciences operates through Protea Biosciences Group, Inc..